Organic Nanocarriers for Bevacizumab Delivery: An Overview of Development, Characterization and Applications
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Organic Nanocarriers for Bevacizumab Delivery: An Overview of Development, Characterization and Applications
Authors
Keywords
-
Journal
MOLECULES
Volume 26, Issue 14, Pages 4127
Publisher
MDPI AG
Online
2021-07-08
DOI
10.3390/molecules26144127
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivo efficacy of bevacizumab-loaded albumin nanoparticles in the treatment of colorectal cancer
- (2020) Inés Luis de Redín et al. Drug Delivery and Translational Research
- Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab
- (2020) Juntao Pang et al. BIOMEDICINE & PHARMACOTHERAPY
- A Critical Review of Biological Properties, Delivery Systems and Analytical/Bioanalytical Methods for Determination of Bevacizumab
- (2020) Leonardo Delello Di Filippo et al. CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY
- An Overview of Properties and Analytical Methods for Lycopene in Organic Nanocarriers
- (2020) Gabriela Corrêa Carvalho et al. CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY
- Chitosan-Coated Lipid-Core Nanocapsules Functionalized with Gold-III and Bevacizumab Induced In Vitro Cytotoxicity against C6 Cell Line and In Vivo Potent Antiangiogenic Activity
- (2020) Aline de Cristo Soares Alves et al. PHARMACEUTICAL RESEARCH
- Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies
- (2020) Anna A. Plyukhova et al. Journal of Clinical Medicine
- Nanoemulsions as Delivery Systems for Poly-Chemotherapy Aiming at Melanoma Treatment
- (2020) Chiara Dianzani et al. Cancers
- Mucoadhesive Electrospun Fibre-Based Technologies for Oral Medicine
- (2020) Jake G. Edmans et al. Pharmaceutics
- Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology
- (2020) Aleksandra Zielińska et al. MOLECULES
- Cyclic RGD Peptide Targeting Coated Nano Drug Co-Delivery System for Therapeutic Use in Age-Related Macular Degeneration Disease
- (2020) Jiaxin Liu et al. MOLECULES
- Novel hybrid lipid nanocapsules loaded with a therapeutic monoclonal antibody – Bevacizumab – and Triamcinolone acetonide for combined therapy in neovascular ocular pathologies
- (2020) María Lina Formica et al. Materials Science & Engineering C-Materials for Biological Applications
- Transscleral Delivery of Bevacizumab-Loaded Chitosan Nanoparticles
- (2019) Nagihan Ugˇurlu et al. Journal of Biomedical Nanotechnology
- Chitosan grafted-poly(ethylene glycol) methacrylate nanoparticles as carrier for controlled release of bevacizumab
- (2019) Corina-Lenuța Savin et al. Materials Science & Engineering C-Materials for Biological Applications
- Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
- (2019) Beatriz García-Pinel et al. Nanomaterials
- In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization
- (2019) Inés Luis de Redín et al. EXPERIMENTAL EYE RESEARCH
- Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles
- (2019) Flávia Sousa et al. JOURNAL OF CONTROLLED RELEASE
- In vitro characterization of new stabilizing albumin nanoparticles as a potential topical drug delivery system in the treatment of corneal neovascularization (CNV)
- (2019) Juan M. Llabot et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications
- (2019) Jiaxin Liu et al. International Journal of Nanomedicine
- Bio-nanotechnological advancement of orally administered insulin nanoparticles: Comprehensive review of experimental design for physicochemical characterization
- (2019) Chun Y. Wong et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
- (2019) Raluca Ioana Teleanu et al. Journal of Clinical Medicine
- Nanoparticles provide long-term stability of bevacizumab preserving its antiangiogenic activity
- (2018) Flávia Sousa et al. Acta Biomaterialia
- Polysaccharide Nanoparticles for Targeted Cancer Therapies
- (2018) Peipei Peng et al. CURRENT DRUG METABOLISM
- Chemokine receptor antagonist block inflammation and therapy Japanese encephalitis virus infection in mouse model
- (2018) Ke Liu et al. CYTOKINE
- Exploiting supramolecular interactions to produce bevacizumab-loaded nanoparticles for potential mucosal delivery
- (2018) Leonardo M.B. Ferreira et al. EUROPEAN POLYMER JOURNAL
- Human serum albumin nanoparticles for ocular delivery of bevacizumab
- (2018) Inés Luis de Redín et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Ocular implant containing bevacizumab-loaded chitosan nanoparticles intended for choroidal neovascularization treatment
- (2018) Parisa Badiee et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Anti-angiogenic treatment (Bevacizumab) improves the responsiveness of photodynamic therapy in colorectal cancer
- (2018) Cheng-Liang Peng et al. Photodiagnosis and Photodynamic Therapy
- Combination of bevacizumab and photodynamic therapy vs. bevacizumab monotherapy for the treatment of wet age‑related macular degeneration: A meta‑analysis of randomized controlled trials
- (2018) Qingquan Wei et al. Experimental and Therapeutic Medicine
- Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
- (2018) M. Danaei et al. Pharmaceutics
- Effect of nanoencapsulation using poly (lactide-co-glycolide) (PLGA) on anti-angiogenic activity of bevacizumab for ocular angiogenesis therapy
- (2018) Xiao-Pei Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Biodegradable core-shell electrospun nanofibers containing bevacizumab to treat age-related macular degeneration
- (2018) Sarah Oliveira Lamas de Souza et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Enhancing anti-cancer activity of erlotinib by antibody conjugated nanofibrin - In vitro studies on lung adenocarcinoma cell lines
- (2018) Sathyaraj Weslen Vedakumari et al. MATERIALS CHEMISTRY AND PHYSICS
- How sugars protect proteins in the solid state and during drying (review): Mechanisms of stabilization in relation to stress conditions
- (2017) Maarten A. Mensink et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Physicochemical characterization of drug nanocarriers
- (2017) Eloísa Berbel Manaia et al. International Journal of Nanomedicine
- Targeted multidrug delivery system to overcome chemoresistance in breast cancer
- (2017) Yuan Tang et al. International Journal of Nanomedicine
- Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies
- (2017) Geoffrey A Pietersz et al. Nanomedicine
- A Natural CCR2 Antagonist Relieves Tumor-associated Macrophage-mediated Immunosuppression to Produce a Therapeutic Effect for Liver Cancer
- (2017) Wenbo Yao et al. EBioMedicine
- A new paradigm for antiangiogenic therapy through controlled release of bevacizumab from PLGA nanoparticles
- (2017) Flávia Sousa et al. Scientific Reports
- Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumab
- (2017) John T. Butterfield et al. Scientific Reports
- Antibody-Targeted Chemotherapy for the Treatment of Melanoma
- (2016) Wendy K. Nevala et al. CANCER RESEARCH
- Albumin nanostructures as advanced drug delivery systems
- (2016) Mahdi Karimi et al. Expert Opinion on Drug Delivery
- Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy?
- (2016) Flávia Sousa et al. Expert Opinion on Drug Delivery
- Characterization and biodistribution of bevacizumab TPGS-based nanomicelles: Preliminary studies
- (2016) Fiorella Tesan et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Antibody-targeted biodegradable nanoparticles for cancer therapy
- (2016) Vahid Heravi Shargh et al. Nanomedicine
- Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer
- (2016) Shifalika Tangutoori et al. Nanomedicine-Nanotechnology Biology and Medicine
- Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents
- (2016) Beverly L. Falcon et al. PHARMACOLOGY & THERAPEUTICS
- Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation
- (2016) Jayamanti Pandit et al. Artificial Cells Nanomedicine and Biotechnology
- Preparation and application of micro/nanoparticles based on natural polysaccharides
- (2015) Jisheng Yang et al. CARBOHYDRATE POLYMERS
- Bevacizumab: A dose review
- (2015) Alexander T. Falk et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
- (2015) Edgar Pérez-Herrero et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment
- (2015) Reyhaneh Varshochian et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- A Novel Thermo-Responsive Nanogel for Intraocular Drug Delivery
- (2015) Chao-Chien Hu et al. Journal of Computational and Theoretical Nanoscience
- Ultrasound-enhanced bevacizumab release from echogenic liposomes for inhibition of atheroma progression
- (2015) Melvin E. Klegerman et al. JOURNAL OF LIPOSOME RESEARCH
- Bevacizumab loaded solid lipid nanoparticles prepared by the coacervation technique: preliminary in vitro studies
- (2015) Luigi Battaglia et al. NANOTECHNOLOGY
- Echogenic nanoparticles for ultrasound technologies: Evolution from diagnostic imaging modality to multimodal theranostic agent
- (2014) Sejin Son et al. Nano Today
- VEGF-targeted cancer therapeutics—paradoxical effects in endocrine organs
- (2014) Yihai Cao Nature Reviews Endocrinology
- Nanoparticles as drug delivery systems
- (2014) Agnieszka Z. Wilczewska et al. Pharmacological Reports
- Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-associated Liposomes
- (2014) Benjamin M. Davis et al. Small
- Techniques for physicochemical characterization of nanomaterials
- (2013) Ping-Chang Lin et al. BIOTECHNOLOGY ADVANCES
- Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration
- (2013) Davin Johnson et al. CURRENT OPINION IN OPHTHALMOLOGY
- The protective effect of albumin on bevacizumab activity and stability in PLGA nanoparticles intended for retinal and choroidal neovascularization treatments
- (2013) Reyhaneh Varshochian et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes
- (2013) Elad Moisseiev et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Investigation of the Stability and Cellular Uptake of Self-Associated Monoclonal Antibody (MAb) Nanoparticles by Non-Small Lung Cancer Cells
- (2013) Asha R. Srinivasan et al. MOLECULAR PHARMACEUTICS
- Nanoparticles in Porous Microparticles Prepared by Supercritical Infusion and Pressure Quench Technology for Sustained Delivery of Bevacizumab
- (2013) Sarath K. Yandrapu et al. MOLECULAR PHARMACEUTICS
- Nanomaterials in combating cancer: Therapeutic applications and developments
- (2013) Samina Nazir et al. Nanomedicine-Nanotechnology Biology and Medicine
- Bevacizumab and micrometastases: Revisiting the preclinical and clinical rollercoaster
- (2013) Giannis Mountzios et al. PHARMACOLOGY & THERAPEUTICS
- Advanced materials and processing for drug delivery: The past and the future
- (2012) Ying Zhang et al. ADVANCED DRUG DELIVERY REVIEWS
- Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab
- (2012) Sung Chul Park et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Bevacizumab as first-line therapy for glioblastoma
- (2012) David Piccioni et al. Future Oncology
- Molecular Characteristics and Pathways of Avastin for the Treatment of Glioblastoma Multiforme
- (2012) Marko Spasic et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Oxide and hybrid nanostructures for therapeutic applications
- (2011) Sudeshna Chandra et al. ADVANCED DRUG DELIVERY REVIEWS
- Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution
- (2011) Sandrine Dufort et al. ADVANCED DRUG DELIVERY REVIEWS
- Are we there yet? Bevacizumab therapy for retinopathy of prematurity
- (2011) Brian A Darlow et al. Archives of Disease in Childhood-Fetal and Neonatal Edition
- Anti-VEGF Therapy With Bevacizumab for Anterior Segment Eye Disease
- (2011) Hamid Hosseini et al. CORNEA
- VEGF gene alternative splicing: pro- and anti-angiogenic isoforms in cancer
- (2011) P. M. Biselli-Chicote et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Albumin-based nanoparticles as potential controlled release drug delivery systems
- (2011) Ahmed O. Elzoghby et al. JOURNAL OF CONTROLLED RELEASE
- Nanomaterials for cancer therapy and imaging
- (2011) Ki Hyun Bae et al. MOLECULES AND CELLS
- Polymer nanoparticles: Preparation techniques and size-control parameters
- (2011) J. Prasad Rao et al. PROGRESS IN POLYMER SCIENCE
- Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability
- (2011) Kenichi Kimoto et al. Journal of Ophthalmology
- Conjugation of bevacizumab to cationic liposomes enhances their tumor-targeting potential
- (2010) Geoffrey M Kuesters et al. Nanomedicine
- FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
- (2010) J. Summers et al. ONCOLOGIST
- Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale
- (2010) Anil Bagri et al. TRENDS IN MOLECULAR MEDICINE
- Biodegradable polymeric nanoparticles based drug delivery systems
- (2009) Avnesh Kumari et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Polymer-based nanocapsules for drug delivery
- (2009) C.E. Mora-Huertas et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION
- (2009) MAJID ABRISHAMI et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Bevacizumab (Avastin) for the Treatment of Ocular Disease
- (2009) Jonathan B. Gunther et al. SURVEY OF OPHTHALMOLOGY
- Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans
- (2008) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Polyethylenimine-coated albumin nanoparticles for BMP-2 delivery
- (2008) Sufeng Zhang et al. BIOTECHNOLOGY PROGRESS
- Vitreous Levels of Bevacizumab and Vascular Endothelial Growth Factor-A in Patients with Choroidal Neovascularization
- (2008) Qi Zhu et al. OPHTHALMOLOGY
- Echogenic Liposome Compositions for Increased Retention of Ultrasound Reflectivity at Physiologic Temperature
- (2007) Kyle D. Buchanan et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started